ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,103, issued on Oct. 20, was assigned to Aragon Pharmaceuticals Inc. (Los Angeles).
"Anticancer compositions" was invented by Geert Verreck (Beerse, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns pharmaceutical formulations of ARN-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (AR)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemi...